Table 1. Baseline and Phadiatop positivity in the study population.
Class§ | Asthma group (n)* | Non-asthma group (n)* | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Phadiatop | hx2 | mx2 | tx4 | wx5 | Phadiatop | hx2 | mx2 | tx4 | wx5 | ||
1 | 21 | 13 | 20 | 9 | 7 | 5 | 3 | 1 | 0 | 0 | |
2 | 36 | 33 | 13 | 12 | 12 | 12 | 9 | 0 | 2 | 2 | |
3 | 25 | 14 | 3 | 1 | 3 | 7 | 3 | 0 | 1 | 1 | |
4 | 28 | 31 | 1 | 0 | 0 | 2 | 3 | 0 | 0 | 0 | |
5 | 17 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
6 | 7 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total | 134 | 111 | 37 | 22 | 22 | 26 | 18 | 1 | 3 | 3 |
*, the number of serum samples tested positive by Phadiatop or by previous ImmunoCAP assays (for hx2, mx2, tx4 and wx5); §, the positive responses are classified by the total Phadiatop or ImmunoCAP sIgE levels as follows: class 1, ≥0.35 and <0.70 kUA/L; class 2, ≥0.70 and <3.50 kUA/L; class 3, ≥3.50 and <17.50 kUA/L; class 4, ≥17.50 and <50.00 kUA/L; class 5, ≥50.00 and <100.00 kUA/L; class 6, ≥100.00 kUA/L. hx2, house dust mix; mx2, molds and yeasts mix; tx4, tree pollen mix; wx5, weed mix.